Award recordCONTRACT

MCKESSON PLASMA AND BIOLOGICS LLC

PIID VA25116P0695· VHA· 515-BATTLE CREEK· 6505 · DRUGS AND BIOLOGICALS· FY2016· $32,724 net obligations· UEI M986PPZNJ8M8· TN

Description

DARZALEX 100MG/5 ML VIAL 16 VI DARZALEX 400MG/20 ML VIAL 32 VI

First action · last action
2016-02-05 · 2016-02-29
Transactions
2
First transaction's obligation
$65,448
Base + all options value (sum of deltas)
$32,724
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$65,448$0Base award · 2016-02-05 · this action $65,448 · running total $65,448Modification P00001 · 2016-02-29 · this action -$32,724 · running total $32,724
  • Base2016-02-05+$65,448= $65,448
  • Mod P000012016-02-29-$32,724= $32,724
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-02-05+$65,448$65,448DARZALEX 100MG/5 ML VIAL 16 VI DARZALEX 400MG/20 ML VIAL 32 VI
Mod P00001· CLOSE OUT2016-02-29−$32,724$32,724DARZALEX 100MG/5 ML VIAL 16 VI DARZALEX 400MG/20 ML VIAL 32 VI

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI M986PPZNJ8M8)

AwardOffice · PSC / listingNet obligationsFY
36C26026P0671260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$18,262FY2026
36C24826P1019248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$16,333FY2026
36C26226P1217262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$16,333FY2026
36C24225P0537242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C25024P0468250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$25,200FY2024
36C25723P0156257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$3,434FY2023

Other recipients under 6505 from 515-BATTLE CREEK (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25116J1237SANOFI VACCINES US INC.515-BATTLE CREEK$7,084FY2016
VA25116J1241SEQIRUS USA INC515-BATTLE CREEK$94,350FY2016
VA25116P1109CARDINAL HEALTH 414, LLC515-BATTLE CREEK$4,097FY2016
VA25116F0195ALEXION PHARMACEUTICALS INC515-BATTLE CREEK$35,317FY2016
VA25116F0089ALEXION PHARMACEUTICALS INC515-BATTLE CREEK$35,317FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25116P0695_3600_-NONE-_-NONE- · retrieved 2026-09-26.